Biotricity (NASDAQ:BTCY) Shares Up 12.6% – Time to Buy?

Biotricity, Inc. (NASDAQ:BTCY) traded up 12.6% during mid-day trading on Friday . The stock traded as high as $0.52 and last traded at $0.45. 84,123 shares changed hands during mid-day trading, an increase of 7% from the average session volume of 78,566 shares. The stock had previously closed at $0.40.

Biotricity Stock Up 12.6 %

The stock has a market cap of $10.19 million, a PE ratio of -0.33 and a beta of 1.22. The stock’s fifty day moving average price is $0.34 and its 200 day moving average price is $0.65.

Biotricity (NASDAQ:BTCY) last issued its earnings results on Monday, August 19th. The company reported ($0.49) EPS for the quarter. The business had revenue of $3.20 million during the quarter. On average, equities research analysts expect that Biotricity, Inc. will post -0.43 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Biotricity stock. AE Wealth Management LLC bought a new position in Biotricity, Inc. (NASDAQ:BTCY) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought 97,751 shares of the company’s stock, valued at approximately $88,000. AE Wealth Management LLC owned 0.45% of Biotricity at the end of the most recent quarter. Institutional investors and hedge funds own 3.89% of the company’s stock.

Biotricity Company Profile

Biotricity, Inc, a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.